Bilan Wang
Impact in
- Drug Discovery top 5%
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 11
- Nanoparticle-Based Drug Delivery 11
-
- Immunotherapy and Immune Responses 7
- Co-authors
- Xiang Gao (16 shared papers)Junli Chen (2 shared papers)Yan Teng (2 shared papers)Haoyuan Wang (1 shared paper)Jianguo Xu (1 shared paper)Kaiyu Wang (1 shared paper)Yongzhong Cheng (1 shared paper)Yuzhu Hu (12 shared papers)
- Journals
- Signal Transduction and Targeted Therapy (3 papers)Oncotarget (2 papers)Journal of Biomedical Nanotechnology (2 papers)Chinese Chemical Letters (2 papers)Bioactive Materials (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Bilan Wang
22 papers receiving 898 citations
Bilan Wang's Hit Papers
Peers
Comparison fields: 5 of 68
- Drug Discovery 10
- Biomaterials 320
- Molecular Medicine 46
- Pharmaceutical Science 44
- Immunology 107
Countries citing papers authored by Bilan Wang
This map shows the geographic impact of Bilan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bilan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bilan Wang more than expected).
Fields of papers citing papers by Bilan Wang
This network shows the impact of papers produced by Bilan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bilan Wang. The network helps show where Bilan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bilan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Current advance of nanotechnology in diagnosis and treatment for malignant tumors Hit paper breakdown → | 2024 | 389 |
| 2 | 2019 | 60 | |
| 3 | 2024 | 58 | |
| 4 | 2017 | 53 | |
| 5 | 2020 | 51 | |
| 6 | 2023 | 48 | |
| 7 | 2018 | 41 | |
| 8 | 2022 | 39 | |
| 9 | 2021 | 34 | |
| 10 | 2017 | 27 | |
| 11 | 2021 | 23 | |
| 12 | 2021 | 19 | |
| 13 | 2021 | 17 | |
| 14 | 2017 | 16 | |
| 15 | 2019 | 13 | |
| 16 | 2021 | 8 | |
| 17 | 2022 | 6 | |
| 18 | 2024 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2025 | 3 |
About Bilan Wang
Bilan Wang is a scholar working on Biomaterials, Immunology, Molecular Biology, Oncology and Cancer Research, having authored 24 papers that have together received 915 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (11 papers), RNA Interference and Gene Delivery (9 papers), Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (3 papers), Nanoplatforms for cancer theranostics (3 papers), Protein Degradation and Inhibitors (2 papers), Breast Cancer Treatment Studies (2 papers) and Hedgehog Signaling Pathway Studies (1 paper). The work is most often cited by research in Drug Discovery (10 citations), Biomaterials (320 citations), Molecular Medicine (46 citations), Pharmaceutical Science (44 citations) and Immunology (107 citations). Bilan Wang has collaborated with scholars based in China and United States. Frequent co-authors include Xiang Gao, Junli Chen, Yan Teng, Haoyuan Wang, Jianguo Xu, Kaiyu Wang, Yongzhong Cheng, Yuzhu Hu, Ting Yu and Yunzhu Lin. Their work appears in journals such as Signal Transduction and Targeted Therapy, Oncotarget, Journal of Biomedical Nanotechnology, Chinese Chemical Letters and Bioactive Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.